LENZ (LENZ Therapeutics) Total Assets : $215.30 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is LENZ Therapeutics Total Assets?

LENZ Therapeutics's Total Assets for the quarter that ended in Dec. 2024 was $215.30 Mil.

During the past 12 months, LENZ Therapeutics's average Total Assets Growth Rate was 36.90% per year. During the past 3 years, the average Total Assets Growth Rate was 507.40% per year.

During the past 4 years, LENZ Therapeutics's highest 3-Year average Total Assets Growth Rate was 507.40%. The lowest was 507.40%. And the median was 507.40%.

Total Assets is connected with ROA %. LENZ Therapeutics's annualized ROA % for the quarter that ended in Dec. 2024 was -23.04%. Total Assets is also linked to Revenue through Asset Turnover. LENZ Therapeutics's Asset Turnover for the quarter that ended in Dec. 2024 was 0.00.

LENZ Therapeutics Total Assets Historical Data

The historical data trend for LENZ Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LENZ Therapeutics Total Assets Chart

LENZ Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Total Assets

18.34

46.95

70.38

215.30

LENZ Therapeutics Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Assets	Get a 7-Day Free Trial					70.38	217.32	202.64	224.01	215.30

LENZ Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

LENZ Therapeutics's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (A: Dec. 2024 )	+	Total Liabilities (A: Dec. 2024 )
	=	204.084	+	11.22
	=	215.30

LENZ Therapeutics's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2024 )	+	Total Liabilities (Q: Dec. 2024 )
	=	204.084	+	11.22
	=	215.30

LENZ Therapeutics (NAS:LENZ) Total Assets Explanation

Total Assets is connected with ROA %.

LENZ Therapeutics's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %	=	Net Income (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	-50.608	/	( (224.007	+	215.304)	/ 2 )
	=	-50.608	/	219.6555
	=	-23.04 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

LENZ Therapeutics's Asset Turnover for the quarter that ended in Dec. 2024 is

	Asset Turnover
=	Revenue (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
=	0	/	( (224.007	+	215.304)	/ 2 )
=	0	/	219.6555
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

LENZ Therapeutics Total Assets Related Terms

Thank you for viewing the detailed overview of LENZ Therapeutics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

LENZ Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LENZ Therapeutics Inc (NAS:LENZ) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

445 Marine View Avenue, STE No. 320, Del Mar, CA, USA, 92014

Website

https://www.lenz-tx.com

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.